• Publications
  • Medicines Patent Pool: Transparency is essent...
Publication - published on 01 Sep 2020

Medicines Patent Pool: Transparency is essential to access to medicines

In this viewpoint for Medicines Patent Pool's "10 Years of MPP" campaign, Executive Director Jayasree K. Iyer discusses the need for transparency from pharmaceutical companies in order to improve access to medicine.

In this piece, Dr. Iyer explains the relationship between the Access to Medicine Foundation and Medicines Patent Pool (MPP), which has become the main driving force behind voluntary licensing in the pharmaceutical industry.

Whether medicines, vaccines and other products reach the people who need them, especially those in low- and middle-income countries, depends on the strategic choices companies make to support affordable access. This viewpoint stresses the need for pharma companies to be transparent about their activities in order to make their medicines more accessible and affordable.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |